-- Nearly 90 percent of consumers are interested in using a self-
monitoring device at home if they developed a condition requiring
-- Twenty percent used an alternative approach to treatment, such as
homeopathic, naturopathic, acupuncture, chiropractic, and bio-electric
therapies; 40 percent might do so in the future.
-- Twelve percent consulted an alternative health care practitioner (for
example, an herbalist, homeopath or chiropractor); 38 percent might do
so in the future.
-- Nine percent substituted an alternative or natural therapy for a
prescription medication; 32 percent might in the future.
-- Thirty-two percent prefer to choose doctors with an orientation toward
holistic or alternative treatments.
-- Fourteen percent are aware of biologic drugs; consumers did not express
a clear preference between biologic and traditional pharmaceuticals.
-- Nearly 40 percent would consider traveling to a foreign country to have
an elective procedure performed if they could save 50 percent or more
and be assured that the quality was equal to or better than what is
available in the United States.
"Life sciences firms should seek to develop products that respond to
consumers' desires for improved capabilities to self-monitor and manage
their own care, and address their interest in alternative and personalized
treatment options, as well as non-conventional delivery models," said Terry
Hisey, vice chairman and industry leader of Deloitte LLP's life sciences
practice. "Insights from our research indicate that there are unmet
consumer needs that present opportunities for pharmaceutical manufacturers,
biotechnology firms, and medical product, technology and device
Copyright©2008 PR Newswire.
All rights reserved